To study the impact of CAR on the expression of liver cancer stem cells, we modulated CAR by activation (using CITCO, in HCC cells and tumorspheres derived from HCC cells) and by CAR knockdown (using siCAR, in HCC cells). Here, NR1I3 is linked to hepatocellular carcinoma.